These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 4272780

  • 1. Digitalis (second of four parts).
    Smith TW, Haber E.
    N Engl J Med; 1973 Nov 08; 289(19):1010-5. PubMed ID: 4272780
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Digitalis: reappraisal of its use after acute myocardial infarction.
    Kones RJ.
    Cardiology; 1974 Nov 08; 59(1):1-20. PubMed ID: 4279003
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Mechanism of action and clinical aspects of digitalis glycosides].
    Streian C, Cristodorescu R, Drăgulescu S, Luca C.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980 Nov 08; 32(3):209-26. PubMed ID: 6113632
    [No Abstract] [Full Text] [Related]

  • 6. Reversal of ouabain and acetyl strophanthidin effects in normal and failing cardiac muscle by specific antibody.
    Gold HK, Smith TW.
    J Clin Invest; 1974 Jun 08; 53(6):1655-61. PubMed ID: 4598113
    [Abstract] [Full Text] [Related]

  • 7. Current aspects of digitalis therapy.
    Karliner JS.
    W V Med J; 1973 Jan 08; 69(1):7-8. PubMed ID: 4509349
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Indications, contraindications, and nonindications for digitalis therapy.
    Duca P, Brest AN.
    Cardiovasc Clin; 1974 Jan 08; 6(2):131-40. PubMed ID: 4613456
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Indications and mode of action of digitalis glycosides. A new hemisynthetic compound: formyl 16 gytoxin].
    Chiche P, Derai C, Melman S, Chekler P.
    Therapeutique; 1970 Jan 08; 46(1):17-24. PubMed ID: 5437772
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vasodilator therapy of cardiac failure (second of two parts).
    Cohn JN, Franciosa JA.
    N Engl J Med; 1977 Aug 04; 297(5):254-8. PubMed ID: 327319
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Changes in the therapy with cardiac glycosides].
    Rietbrock N.
    MMW Munch Med Wochenschr; 1982 Jun 04; 124(22):539-40. PubMed ID: 6808381
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The importance of cardiac glycoside therapy. Digitalis--to use or not to use?].
    Jerie P.
    Ther Umsch; 1984 Feb 04; 41(2):96-102. PubMed ID: 6369617
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.